Growth Metrics

Legend Biotech (LEGN) Total Debt (2021 - 2025)

Historic Total Debt for Legend Biotech (LEGN) over the last 5 years, with Q3 2025 value amounting to $142.9 million.

  • Legend Biotech's Total Debt fell 5183.35% to $142.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $142.9 million, marking a year-over-year decrease of 5183.35%. This contributed to the annual value of $281.3 million for FY2023, which is 781.66% up from last year.
  • As of Q3 2025, Legend Biotech's Total Debt stood at $142.9 million, which was down 5183.35% from $310.3 million recorded in Q2 2025.
  • Legend Biotech's Total Debt's 5-year high stood at $310.3 million during Q2 2025, with a 5-year trough of $17310.0 in Q2 2021.
  • Over the past 5 years, Legend Biotech's median Total Debt value was $270.6 million (recorded in 2023), while the average stood at $220.4 million.
  • Per our database at Business Quant, Legend Biotech's Total Debt soared by 11660.94% in 2022 and then plummeted by 5183.35% in 2025.
  • Over the past 5 years, Legend Biotech's Total Debt (Quarter) stood at $120.5 million in 2021, then soared by 116.61% to $260.9 million in 2022, then grew by 7.82% to $281.3 million in 2023, then increased by 5.44% to $296.6 million in 2024, then tumbled by 51.83% to $142.9 million in 2025.
  • Its Total Debt was $142.9 million in Q3 2025, compared to $310.3 million in Q2 2025 and $305.7 million in Q1 2025.